Bond.az White LogoBond.az Black Logo
→
EN ▾
AZENRU
Snap CTO Sells $21.4M in Company SharesCrowdstrike CEO sells over $1.1M in stockKBR director Von Thaer Lewis buys $92,310 in stockTrio-Tech director sells $123,570 in common stockJames Bond Casting BeginsWheels Up CSO Briffa sells $18,981 in stockApogee CEO Michael Henderson sells $1.64m in stockAmazon sued over Trump tariff refundsRegeneron melanoma drug trial misses primary endpointKBR CFO Shad Evans buys $256,275 in stockSnap CTO Sells $21.4M in Company SharesCrowdstrike CEO sells over $1.1M in stockKBR director Von Thaer Lewis buys $92,310 in stockTrio-Tech director sells $123,570 in common stockJames Bond Casting BeginsWheels Up CSO Briffa sells $18,981 in stockApogee CEO Michael Henderson sells $1.64m in stockAmazon sued over Trump tariff refundsRegeneron melanoma drug trial misses primary endpointKBR CFO Shad Evans buys $256,275 in stock
Personalize
Bond.az White LogoBond.az Black Logo
AZENRU

#plus-therapeutics

Latest news and interesting information about plus-therapeutics.

Plus Therapeutics shareholders approve board elections and key proposals at annual meeting
Yesterday / 23:23
|
852

Plus Therapeutics shareholders approve board elections and key proposals at annual meeting

Plus Therapeutics shareholders voted on four proposals at the 2026 annual meeting, including board elections, auditor ratification, executive compensation, and stock plan amendment.

SEC FILINGS →
0
...